warrants exercised 5 452 - 457 - (3) Increase/(Decrease) in Net Debt on cash basis 49 (364) 15 (154) 585 (126)% Note: (1) Includes inventory gain/ (loss) (2) Includes net proceeds from disposals of PPE
impacted by inventory gains/losses wherein inventory gains decrease the cost of sales and inventory losses increase the cost of sales. Net Operating Debt is Net Debt (total debt less cash and current
Perp interest (76) (59) (49) (159) (105) 52% Proceeds from issue of ordinary shares due to warrants exercised 452 0 - 452 (0) (3) Increase/(Decrease) in Net Debt on cash basis (364) 212 (111) (187) 562
PERP interest (128) (106) (76) 68% (254) (159) 60% Proceeds from issue of ordinary shares due to warrants exercised 84 183 452 498 452 Increase/(Decrease) in Net Debt on cash basis3 306 345 (364) 404
) Increase/(Decrease) in Net Debt on cash basis 212 (51) 275 66 788 (92)% Note: (1) Includes inventory gain/ (loss) (2) Includes net proceeds from disposals of PPE, other non-current investments and assumed
shares due to warrants exercised 0 (3) 227 (100)% 264 683 (61)% Increase/(Decrease) in Net Debt on cash basis3 (296) (777) 295 (200)% (1,948) 398 (590)% 1 Includes inventory gains/ (losses) 2 Includes net
% (312) (155) 101% Proceeds from issue of ordinary shares due to warrants exercised 0 (3) 227 (100)% 264 683 (61)% Increase/(Decrease) in Net Debt on cash basis3 (296) (777) 295 (200)% (1,948) 398 (590)% 1
) (18) (2)% (68) (43) 59% Dividends and PERP interest (106) (8) (59) 79% (202) (132) 54% Proceeds from issue of ordinary shares due to warrants exercised 183 227 0 866 0 Increase/(Decrease) in Net Debt on
(%) 12.02 15.64 (3.62) Profit before FX per share (Baht) 4.70 4.88 (0.18) Leverage Ratio and Liquidity Ratio Quarter 3 Quarter 2 Change Increase/(Decrease) 2019 2019 Debt to Equity Ratio (Time) - Consolidated